Precision Neuroscience
- Health & Biotech
- New York, NY, US
- Founded 2021
- Private
- precisionneuro.io
Builds thin-film brain-computer interface implants that read and stimulate neural activity from the brain surface for patients with paralysis.
$250MEquity raised in 2025–20262025 — · 2026 $250M · 1 equity round
$250MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 1 round · 3 sources
Earlier rounds not yet sourced. Precision Neuroscience was founded in 2021 and raised before 24 Sep 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.
- Series DAmount$250MPost-money—✓ Confirmed
- Earlier rounds not yet sourced
Investors 11
- Ackman Oxman Institute1
- Pershing Square1
- ARK Invest
- B Capital
- Duquesne Family Office
- Hitachi
- Invus
- JSL Health Capital
- Korea Investment Partners
- Mirae Asset
- Mubadala
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
CrusoeAI Infra · $5.3B in 2025–2026Shared: MubadalaApptronikRobotics · $935M in 2025–2026Shared: B CapitalRebellionsAI Infra · $650M in 2025–2026Shared: Mirae AssetFervo EnergyEnergy · $462M in 2025–2026Shared: B CapitalOllin BiosciencesHealth · $430M in 2025–2026Shared: MubadalaCellaresHealth · $327M in 2025–2026Shared: Duquesne Family Office, ARK Invest
Also in the New York hub see on the globe
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Precision Neuroscience and its logo are trademarks of their owners, used here for identification only.
